A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength. - Wikidata - awgldk - TriplyDB

A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength.

A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength.

http://www.wikidata.org/entity/Q37595428

about

Myostatin: expanding horizons Effect of Postnatal Myostatin Inhibition on Bite Mechanics in Mice Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease Therapies for musculoskeletal disease: can we treat two birds with one stone?Single muscle fiber gene expression with run taper.Biomechanical aspects of the muscle-bone interaction Effects of myokines on bone.Effect of the Lipoxygenase Inhibitor Baicalein on Muscles in Ovariectomized Rats.Integrated therapies for osteoporosis and sarcopenia: from signaling pathways to clinical trials.Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication.Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.Influence of exercise and aging on extracellular matrix composition in the skeletal muscle stem cell niche.Serum myostatin in central south Chinese postmenopausal women: Relationship with body composition, lipids and bone mineral density.Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.Anatomic changes in the macroscopic morphology and microarchitecture of denervated long bone tissue after spinal cord injury in rats.GDF8 inhibits bone formation and promotes bone resorption in mice.Intrinsic muscle clock is necessary for musculoskeletal health.Role of follistatin in muscle and bone alterations induced by gravity change in mice.Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.Neonatal Systemic AAV-Mediated Gene Delivery of GDF11 Inhibits Skeletal Muscle Growth.Effect of exercise on bone in poorly controlled type 1 diabetes mediated by the ActRIIB/Smad signaling pathway

P2860

Q26797484-D5FACE21-D970-4773-8141-C2191C40EA85 Q27301008-F10496C8-0C6C-4B54-B115-3E2ED74B59BD Q28606560-9AC9D677-0697-4C09-83E9-2B7CCCD9E276 Q33851441-5FC6CF00-FC9A-49E2-BA22-2A8B1208A687 Q34277356-1696BBD7-1E40-4C96-9AFE-2381310211F7 Q35014005-81E566D9-D915-4A65-BF43-33454F2D4E86 Q37112054-BED50449-D8E0-47E3-9BF7-0043EC93BA3C Q37512688-9B161DF4-8AB5-4F46-8A8C-6EFF2CB59686 Q38336740-F608F20F-6833-43AC-9632-A75AE5E27DB5 Q38705141-0654CC2E-1E48-40CD-BE71-2433D66C14A4 Q38912441-3D560E7E-DDCD-4D56-9E30-4E1CBF0D3C00 Q38931350-DD45AC0E-4622-42A5-8F7C-4EB25059CB94 Q39795648-FC189465-0C37-4109-8694-3272C7238DAF Q40956001-09922776-DFB7-4419-9267-1272CF34ECD9 Q42130804-33721EB4-0F97-467E-95B6-AA8149FB92BB Q46275955-9F8B1BBA-C4C2-4031-BD0C-CCCA7134311A Q48072193-AD0A12F9-5AE0-4F9D-80D0-C54E8A4024EE Q48192017-A814B748-B30D-4352-B44A-3F7C63D07AC3 Q52864293-52299941-AF3D-4B81-919F-B895EB5ACD83 Q54262478-9CB0963E-AC30-4DC5-8087-9ADE83E62BA3 Q58784211-A4A95195-ACED-40D8-BAC8-958C4EBA7653

P2860

A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength.

http://www.wikidata.org/entity/Q37595428

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A myostatin inhibitor (propept ...... bone density or bone strength.

@en

A myostatin inhibitor

@nl

type

label

A myostatin inhibitor (propept ...... bone density or bone strength.

@en

A myostatin inhibitor

@nl

prefLabel

A myostatin inhibitor (propept ...... bone density or bone strength.

@en

A myostatin inhibitor

@nl

P1433

Q37595428-5B4BF424-42A9-475A-BE22-E4BCCA33B7BD

P1476

Q37595428-F37024EB-34C7-45F0-A5AB-387172340FF0

P2093

Q37595428-0054ED82-7772-489E-8711-D34F0B60339F

Q37595428-6C397F3D-7282-46E7-A8D3-39A19393BCD4

Q37595428-84CDBFB0-92D7-4EA3-8342-8981FFCBB24A

Q37595428-90B5BD0E-7127-4544-8E20-5C24E4712ED2

Q37595428-BBD9CAFB-4B27-4388-B8BB-8D322DAD5955

Q37595428-D0CBCE30-53E6-4A36-8725-8320443DD0F3

Q37595428-D2A69899-1B81-4FB3-A534-878F0968CE12

Q37595428-D8A91ECC-C975-43E4-B5CA-3CA017DD422E

Q37595428-EEB606EB-5727-4ACE-A9AE-9A16C6AE1673

P2860

Q37595428-0C1589CD-5247-464F-ABB7-DDC96758D644

Q37595428-2DFE54ED-5912-4AC7-A25A-15E18F722080

Q37595428-4267915E-C470-4A77-94C0-F57FB8B193ED

Q37595428-455F5181-4AEC-4C41-99C0-7C1F999BCE1D

Q37595428-4B0E3BD7-BDC5-4359-9FA2-C78C7C99EC38

Q37595428-4EAFE71A-BDD4-42BE-AD9B-33A126594C02

Q37595428-58487985-1F94-49B6-952C-86E20C2F83A5

Q37595428-7C79DADF-BC99-4153-AD0C-A1B0DBDE00AC

Q37595428-802204E8-EE4C-475B-82CA-F5F1E2801285

Q37595428-808E030C-9FC9-4BA1-842B-20748E66721C

P304

Q37595428-A335CE0A-DCB3-4BDE-BD41-D346122FFB5D

P31

Q37595428-4D74DB61-F46B-4DD7-B312-353B17B55861

P356

Q37595428-9A0D6473-B22E-4A54-B1BD-3F51EDA3F999

P433

Q37595428-52FD87AB-8AF3-4F58-A879-E23FF8FCE931

P478

Q37595428-24DDED04-7262-4430-B7E7-554A9642B2AF

P577

Q37595428-A4992E37-E03A-4E63-8A50-769BA1175555

P5875

Q37595428-0E0E4B19-3BA1-407F-A5A3-77A0767BEDF4

P698

Q37595428-A5A32784-C6BF-41F4-BA70-9AE66ADC5B34

P932

Q37595428-FEC0C6FD-50F2-48F9-881A-46144E84B193

P356

J.EXGER.2013.06.004

P1433

Experimental Gerontology

P1476

A myostatin inhibitor (propept ...... bone density or bone strength.

@en

P2093

Carlos M Isales

http://www.w3.org/2001/XMLSchema#string

Li-Fang Liang

http://www.w3.org/2001/XMLSchema#string

Maribeth Johnson

http://www.w3.org/2001/XMLSchema#string

Mark W Hamrick

http://www.w3.org/2001/XMLSchema#string

Mohammed Elsalanty

http://www.w3.org/2001/XMLSchema#string

Peter Bialek

http://www.w3.org/2001/XMLSchema#string

Phonepasong Arounleut

http://www.w3.org/2001/XMLSchema#string

Sadanand Fulzele

http://www.w3.org/2001/XMLSchema#string

Sunil Upadhyay

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight.

Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.

Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing.

Shifting the focus in fracture prevention from osteoporosis to falls

Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells

The skeletal muscle secretome: an emerging player in muscle-bone crosstalk

Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury.

Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression

P304

898-904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXGER.2013.06.004

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247157141

http://www.w3.org/2001/XMLSchema#string

P698

23832079

http://www.w3.org/2001/XMLSchema#string

P932

3930487

http://www.w3.org/2001/XMLSchema#string